Remission of graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment

Thyroid

Volumn 10, Issue 10, 2000, Pages 891-896

  Takasu, N ^a   Yamashiro, K ^a   Komiya, I ^a   Ochi, Y ^b   Sato, Y ^c   Nagata, A ^c  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b RESEARCH INSTITUTE FOR PRODUCTION DEVELOPMENT   (Japan)

^c YAMASA CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; LIOTHYRONINE; THYROID STIMULATING IMMUNOGLOBULIN; THYROTROPIN; THYROXINE;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN BINDING; REMISSION; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TREATMENT OUTCOME;

EID: 0033777563     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2000.10.891     Document Type: Article

References (13)

1. Reappraisal of the 3,5,3'-triiodothyronine-suppression test in the prediction of long term outcome of antithyroid drug therapy in patients with hyperthyroid Graves' disease
2. Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis
3. Measurement of thyrotropin receptor antibodies
4. A new in vitro assay for human thyroid stimulator using cultured thyroid cells: Effect of sodium chloride on adenosine 3',5'-monophosphate increase
5. Functionality of thyroid-stimulating antibodies assessed by cryopreserved human thyroid cell bioassay
6. Clinical experience with a human thyroid cell bioassay for thyroid-stimulating immunoglobulin
7. Development of a kit for detection of thyroid stimulating antibody
8. Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects
9. Advances in statistical methodology for the evaluation of diagnostic and laboratory tests
10. An analysis of thyrotrophin receptor binding and thyroid stimulating activities in a series of Graves' sera
11. Recent progress in TSH receptor studies with a new concept of 'autoimmune TSH receptor disease.'
12. Prospective multicentre study on the prediction of relapse after antithyroid drug treatment in patients with Graves' disease
13. Simple and reliable method for predicting the remission of Graves' disease: Revised triiodothyronine-suppression test, indexed by serum thyroxine